1.AMD advanced again. All Hail CEO Lisa Su. At this rate the stock’s PT is $15 within the next 30 days and $20 by the end of the year. Agree?2.Readers were unhappy with the $19 - $30 PT on Valeant Pharmaceuticals (VRX). They could have adjusted the revenue forecasts to arrive at a different forecast using this finbox.io model.Note: Here is the article -- VRX PT $30 (links to seekingalpha).3.Dryships (DRYS) continued its spiral lower. Months before the split, a fellow DIY Value Investing member asked about DRYS. I said it was not a good holding.4.Himax (HIMX) pulled back slightly but the mid-term outlook is positive. It’s Asia’s time to make 8K TV’s mainstream.5.Teva Pharmaceuticals (TEVA), a value pick I believed bottomed, took a run towards $37.6.Oclaro (OCLR) tumbled ~11% on NO news. The upward channel in the $8 - $11 is in place.7.PENDING: An article on Apple PT $183 (1 trillion dollar market cap)8.Exact Sciences (EXAS) is on the expensive side of valuation but revenue growth expectations are low. EXAS will outperform.9.Tesla (TSLA) reported quarterly results. More of the same. No news. $280 a top.10.In the cyclical sector, CLF, FCX, and CHK all fell. Vale dropped slightly.11.Twitter is $16/share. I shared impression and traffic statistics (10,000 /week, 30,000 a month) and click-through data to DIY members. It gives a negative story on the company. A buyout is just a hope. Higher usage via live events could bring TWTR back to $20.What stocks are you watching? Post in the comments below. Sign in via StockTwits.